Department of Medicine

HLA Gene Editing to Treat Refractory Rheumatoid Arthritis

Written by Department of Medicine | November 15, 2022

Watch the Department of Medicine's Nov. 15, 2022 Research & Innovation Conference: "HLA Gene Editing to Treat Refractory Rheumatoid Arthritis" with Brian Freed, PhD, FACHI, Executive Director, ClinImmune Cell & Gene Therapy; professor of medicine and immunology, Division of Allergy, Asthma and Clinical Immunology, Department of Medicine, University of Colorado School of Medicine.